U.S. Clinical Trial Enterprise Falls Short In FDA-Funded Study
This article was originally published in The Gray Sheet
Executive Summary
Small, single-center clinical studies dominate the list of trials that were registered on the government’s ClinicalTrials.gov between 2007 and 2010, researchers reported May 2.
You may also be interested in...
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.